Which companies are Aspen Neuroscience's closest peers?

The cockpit's peer set: Zhejiang Laifual Drive (3952.HK), Lyell Immunopharma (LYEL), Allogene Therapeutics (ALLO), Surrozen (SRZN), Medtide (3880.HK), Viva Biotech (1873.HK), G2GBIO (456160.KS), AgomAb Therapeutics NV ADR (AGMB).

← CockpitCompetitor Analysis › ASPE Aspen Neuroscience, Inc.Open in the cockpit ↗

Aspen Neuroscience, Inc.ASPECompetitor analysis, valuation and peers

United States · USD·Health Care›Biotechnology

Competitor Analysis ▸ Charts Open in the cockpit

Mkt cap

$362M

US dollars, full cap

$/day

$7.28M

20-day average traded

Fwd P/E

n/m

no positive forecast

ROIC−WACC

-195.2 pp

WACC 8.8%

Hurdle

n/a

no reverse DCF

Close · USD$12.44

1D+5.8%

1W-16.4%

1Mn/a

3Mn/a

6Mn/a

YTDn/a

1Yn/a

What Aspen Neuroscience does

Employees: 117

Aspen Neuroscience at a glance

Size Aspen Neuroscience (ASPE) is a United States Health Care company (Biotechnology) with a market value of $362M, the 2948th largest of 3,117 United States companies the cockpit tracks. Shares closed at $12.44 on 6 Nov 2026.

Capital Return on invested capital runs 195.2 points below its cost of capital (8.8% WACC).

Aspen Neuroscience financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
	TTM	FY2025	FY2024
Revenue	n/a	$0	$0
Revenue growth	—	—	—
Gross profit	n/a	-$4.20M	-$3.70M
EBITDA	n/a	-$55.1M	-$49.8M
Net income	n/a	-$62.1M	-$48.6M
Free cash flow	n/a	-$62.5M	-$46.8M
Capital expenditure	n/a	$9.69M	$2.58M
Total debt	$349M	$350M	$237M

Quarterly statements and history in the cockpit →

Aspen Neuroscience competitors and peer comparison

How Aspen Neuroscience compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Aspen Neuroscience against its 20 peers (data as of 6 Nov 2026)
Measure	ASPE	Peer median	Rank in peer set
ROIC minus cost of capital	-195.2 pp	-41.2 pp	lowest of 13

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
Company	Market	Market cap	6M return	Revenue growth	Op. margin	EV / Sales	Req g	Delivered g
Aspen Neuroscience ASPE	United States	$362M	n/a	n/a	n/a	n/a	n/a	n/a
Zhejiang Laifual Drive 3952.HK	Hong Kong	$363M	n/a	+142%	-11%	7.1×	n/a	n/a
Lyell Immunopharma LYEL	United States	$364M	-23%	-55%	-729,281%	7,653.4×	n/a	n/a
Allogene Therapeutics ALLO	United States	$359M	-54%	-100%	-3,886%	22.8×	n/a	n/a
Surrozen SRZN	United States	$364M	-35%	-9%	-385%	23.3×	n/a	n/a
Medtide 3880.HK	Hong Kong	$358M	-9%	+14%	36%	2.7×	n/a	n/a
Viva Biotech 1873.HK	Hong Kong	$354M	-14%	+7%	10%	1.2×	5.6%	+19.1%
G2GBIO 456160.KS	South Korea	$370M	-65%	-45%	-2,884%	775.0×	n/a	n/a
AgomAb Therapeutics NV ADR AGMB	United States	$376M	-37%	n/a	n/a	n/a	n/a	n/a
ProKidney PROK	United States	$345M	-39%	+55%	-21,665%	1,556.3×	n/a	n/a
Fennec Pharmaceuticals FENC	United States	$344M	+42%	+78%	-3%	5.1×	n/a	n/a
Contineum Therapeutics CTNM	United States	$381M	-34%	n/a	n/a	n/a	n/a	n/a
C4 Therapeutics CCCC	United States	$381M	+5%	+2%	-288%	5.3×	n/a	n/a
Guangdong Vtr Bio-Tech 300381.SZ	China	$384M	-23%	-4%	-4%	2.7×	n/a	n/a
Cuorips 4894.T	Japan	$341M	-9%	-51%	-947%	392.1×	n/a	n/a
Alector ALEC	United States	$340M	+9%	-83%	-857%	14.4×	n/a	n/a
Rznomics 476830.KS	South Korea	$386M	-79%	-72%	-1,440%	244.5×	n/a	n/a
Beijing Luzhu Biotechnology 2480.HK	Hong Kong	$390M	-33%	n/a	n/a	n/a	n/a	n/a
Onconic Therapeutics 476060.KS	South Korea	$391M	-45%	+179%	21%	5.7×	2.0%	+725.2%
Benitec Biopharma BNTC	United States	$333M	-22%	n/a	n/a	n/a	n/a	n/a
PureTech Health PRTC.L	United Kingdom	$394M	-8%	-4%	-1,617%	28.4×	n/a	n/a

Questions

Which companies are Aspen Neuroscience's closest peers?: The cockpit's peer set: Zhejiang Laifual Drive (3952.HK), Lyell Immunopharma (LYEL), Allogene Therapeutics (ALLO), Surrozen (SRZN), Medtide (3880.HK), Viva Biotech (1873.HK), G2GBIO (456160.KS), AgomAb Therapeutics NV ADR (AGMB).